| Glucose-transporter-mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients. | |
| | |
MedLine Citation:
|
PMID: 20045149 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Insulin causes inotropic effects via Ca(2+)-dependent and Ca(2+)-independent pathways. The latter one is potentially glucose dependent. We examined inotropic responses and signal transduction of insulin in human atrial myocardium of diabetic and nondiabetic patients to test for the role of glucose transporters. Experiments were performed in isolated atrial myocardium of 88 patients undergoing cardiac surgery and 28 ventricular muscle samples of explanted hearts. Influence of insulin (0.02 micromol/L) on isometric twitch force was examined with and without blocking glucose transporter (GLUT) 4 translocation (latrunculin), sodium-coupled glucose transporter (SGLT) 1 (phlorizin, T-1095A), or PI3-kinase (wortmannin). Experiments were performed in Tyrode solution containing glucose or pyruvate as energetic substrate. Messenger RNA expression of glucose transporters (GLUT1, GLUT4, SGLT1, SGLT2) was analyzed in atrial and ventricular myocardium of both diabetic and nondiabetic patients. Developed force increases after insulin (to 117.8% +/- 2.4% and 115.8% +/- 1.9%) in trabeculae from patients with and without diabetes. Inotropic effect was reduced after displacing glucose with pyruvate as well as after PI3-kinase inhibition (to 103% +/- 2%) or inhibition of glucose transporters GLUT4 (to 105% +/- 2%) and SGLT1 (phlorizin to 106% +/- 2%, T-1095A to 105% +/- 2%), without differences between the 2 groups. In glucose-free pyruvate-containing solution, only inhibition of PI3-kinase but not blocking glucose transporters resulted in further inhibitory effects. Messenger RNA expression did not show significant differences between patients with or without diabetes. Insulin exerts positive inotropic effects in human atrial myocardium. These effects are mediated via a PI3-kinase-sensitive and a glucose-transport-sensitive pathway. Differences in functional effects or messenger RNA expression of glucose transporters were not detectable between patients with and without diabetes. |
| | |
Authors:
|
Dirk von Lewinski; Peter P Rainer; Robert Gasser; Marie-Sophie Huber; Mounir Khafaga; Bastian Wilhelm; Tobias Haas; Heinrich M?chler; Ulrich R?ssl; Burkert Pieske |
Related Documents
:
|
8994059 - Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: inv... 10489929 - Effect of a dietary nonionic surfactant on small intestinal nutrient transport. 11304809 - Quantitative immunohistochemistry of glucose transport protein (glut3) expression in th... 1390829 - Phloretin keto-enol tautomerism and inhibition of glucose transport in human erythrocyt... 3778899 - Kinetics of glucose transport in human erythrocytes: zero-trans efflux and infinite-tra... 1707549 - Kinetics of glucose decarboxylation in the substrate-limited isolated perfused kidney. 21168319 - The binary switch that controls the life and death decisions of er stressed β cells. 10532529 - Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney ... 12878829 - Diabetic heart dysfunction: is cell transplantation a potential therapy? |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't Date: 2009-12-31 |
Journal Detail:
|
Title: Metabolism: clinical and experimental Volume: 59 ISSN: 1532-8600 ISO Abbreviation: Metab. Clin. Exp. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-06-07 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375267 Medline TA: Metabolism Country: United States |
Other Details:
|
Languages: eng Pagination: 1020-8 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Medical University Graz, Graz, Austria. dirk.von-lewinski@medunigraz.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
1-Phosphatidylinositol 3-Kinase
/
metabolism Aged Cardiotonic Agents / pharmacology Diabetes Mellitus / metabolism, physiopathology* Female Glucose / metabolism Glucose Transport Proteins, Facilitative / biosynthesis, genetics, physiology* Heart Atria Humans Hypoglycemic Agents / pharmacology Insulin / pharmacology Male Middle Aged Myocardial Contraction / physiology* Myocardium / cytology, metabolism Pyruvic Acid / metabolism RNA, Messenger / biosynthesis, genetics Sodium-Glucose Transporter 1 / biosynthesis, genetics |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 0/Glucose Transport Proteins, Facilitative; 0/Hypoglycemic Agents; 0/RNA, Messenger; 0/Sodium-Glucose Transporter 1; 11061-68-0/Insulin; 127-17-3/Pyruvic Acid; 50-99-7/Glucose; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the me...
Next Document: Adipose tissue lamin A/C messenger RNA expression in women.